Stimulatory effects of L-5-hydroxytryptophan on postdexamethasone β-endorphin levels in major depression

Neuropsychopharmacology

Volumn 15, Issue 4, 1996, Pages 340-348

  Maes, Michael ^a,b,c   Van Gastel, Ann ^d   Ranjan, Rakesh ^a   Blockx, Pierre ^d   Cosyns, Paul ^b   Meltzer, Herbert Y ^a   Desnyder, Roger ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Stuivenberg General Hospital   (Belgium)

^d NONE

Author keywords

5 Hydroxytryptophan; ACTH; Cortisol; Depression; Dexamethasone suppression test; Serotonin; Endorphin

Indexed keywords

5 HYDROXYTRYPTOPHAN; BETA ENDORPHIN; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030272770     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00238-9     Document Type: Article

References (54)

1. Abou-Samra AB, Fevre-Montange M, Loras B, Durand A, Tourniaire J, Bertrand J (1985): Effect of indolamines on beta-endorphin release by rat anterior pituitary cells. Neuroendocrinology 41:490-493
2. American Psychiatric Association (1980): Diagnostic and Statistical Manual of Mental Disorders, ed. 3. Washington, DC, American Psychiatric Association
3. Anderson IM, Cowen PJ, Grahame-Smith DG (1990): The effects of gepirone on neuroendocrine function and temperature in humans. Psychopharmacology 100:498-503
4. Bagdy G, Calogero AE, Szemeredi K, Gomez MT, Murphy DL, Chrousos GP, Gold PW (1990): Beta-endorphin responses to different serotonin agonists: Involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action. Brain Res 537:227-232
5. Ball R, Hewlett T, Silverstone T, Rees L (1987): The interrelationship of beta endorphin, ACTH and cortisol in depressive illness: A controlled study. Psychol Med 17:31-37
6. Calogero AE, Bagdy G, Moncada ML, Dagata R (1993): Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone-induced and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol 136:381-387
7. Cancela LM, Fulginiti S, Ramirez OA (1985): Involvement of a serotonergic control in the regulation of plasma levels of immunoreactive beta-endorphin. Acta Physiol Pharmacol Latinoam 35:409-413
8. Carr JA, Saland LC, Samora A, Benavidez S, Krobert K (1991): In vivo effects of serotonergic agents on alpha-melanocyte-stimulating hormone secretion. Neuroendocrinology 54:616-622
9. Carroll BJ (1980): Clinical application of neuroendocrine research in depression. In van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ (eds), Handbook of Biological Psychiatry, Part III: Brain Mechanisms and Abnormal Behavior-Genetics and Neuroendocrinology. New York, Marcel Dekker, pp 179-193
10. Cella S, Penalva A, Locatelli V, Novelli A, Cocchi D, Muller EE (1983): Neuroendocrine studies with fluvoxamine: Animal data. Br J Clin Pharmacol 15:357-364
11. Chaouloff F (1993): Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18:1-32
12. Dean B, Kolavcic M, Tizian L, Harrison L (1986): Should plasma β-endorphin be measured in patients with disorders of the hypothalamic-pituitary-adrenal axis? Clin Chem 32:895
13. A receptor stimulation. Endocrinology 127:567-572
14. Facchinetti F, Martignoni E, Nappi G, Marini S, Petraglia F, Sandrini G, Genazzani AR (1987): Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion. Horm Res 27:42-46
15. Fukata J, Nakai Y, Imura H, Takeuchi J (1984): Effects of serotonin depleters on the contents of beta-endorphin, alpha-melanotropin and adrenocorticotropin in rat brain and pituitary. Brain Res 324:289-293
16. Fuller RW (1992): The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 13:250-270
17. Gispen-de-Wied CC, Westenberg HG, Thijssen JH, Van Ree JM (1987): The dexamethasone and cortisol suppression test in depression: Beta-endorphin as a useful marker. Psychoneuroendocrinology 12:355-366
18. Guillemin R, Vargo T, Rossier J, Minick S. Ling N, Rivier C, Vale W, Bloom F (1977): β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197:1367-1369
19. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61
20. Jackson RV, DeCherney GS, DeBold CR, Sheldon WR, Alexander AN, Rivier J, Vale W, Orth DN (1984): Synthetic ovine corticotropin-releasing hormone: Simultaneous release of proopiolipomelanocortin peptides in man. J Clin Endocrinol Metab 58:740-743
21. Krantz DE, Brown WA (1985): Dexamethasone suppresses beta-endorphin in humans. Psychoneuroendocrinology 10:211-214
22. Koenig JI, Gudelsky GA, Meltzer HY (1987): Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 137:1-8
23. Lee MA, Nash JF, Barnes M, Meltzer HY (1991): Inhibitory effect of ritanserin on the 5-hydroxy-tryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology 103:258-264
24. Lin SC, Maruta T, Newman DC, Kao PC (1986): Plasma levels of cortisol, corticotropin, and beta endorphin in patients with major depression. J Clin Psychiatry 47:413-414
25. Maes M, Meltzer HYM (1995) The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology, the Fourth Generation of Progress. New York, Raven Press, pp 933-944
26. Maes M, De Ruyter M, Claes R, Bosma G, Suy E (1987): The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients. J Affect Disord 13:23-30
27. Maes M, Vandewoude M, Schotte C, Cosyns P (1989): Results of the 8 A.M. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis melancholia: A test unaffected by the variations in the bioavailability of dexamethasone. Neuropsychobiology 22:26-32
28. Maes M, Jacobs M-P, Suy E, Leclercq C, Christiaens F, Raus J (1990): An augmented escape of β-endorphins to suppression by dexamethasone in severely depressed patients. J Affect Disord 18:149-156
29. Maes M, D'Hondt P, Martin M, Claes M, Schotte C, Vandewoude M, Blockx P (1991a): L-5-hydroxytryptophan simulated cortisol escape from dexamethasone suppression in melancholic patients. Acta Psychiatr Scand 83:302-306
30. Maes M, Vandervorst C, Suy E, Minner B, Raus J (1991b): A multivariate study on the simultaneous urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and β-endorphin escape from suppression by dexamethasone in melancholic patients. Acta Psychiatr Scand 83:480-491
31. Maes M, Claes M, Vandewoude M, Schotte C, Martin M, Blockx P, Cosyns P (1992): Adrenocorticotropin hormone, β-endorphin and cortisol responses to oCRH in melancholic patients. Psychol Med 22:317-329
32. Maes M, Meltzer HY, Cosyns P, Calabrese J, D'Hondt P, Blockx P, Vandervorst C, Raus J (1993): Pituitary and adrenal hormone responses to Synacthen in melancholic versus minor depressed subjects. Biol Psychiatry 33:624-629
33. Maes M, Meltzer HY, Cosyns P, Calabrese J, D'Hondt P, Blockx P (1994): Adrenocorticotropic hormone, β-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone. Prog Neuro-Psychopharmacol Biol Psychiatry 18:1273-1292
34. Maes M, D'Hondt P, Meltzer HY, Cosyns P, Blockx P (1995): Effects of serotonin agonists on the negative feedback by glucocorticoids on the hypothalamic-pituitary-adrenal axis in depression. Psychoneuroendocrinol 20:149-167
35. McLoughlin L, Tomlin S, Grossman A, Lytras N, Schally AV, Coy D, Besser GM, Rees LH (1984): CRH-41 stimulates the release of β-lipotrophin and β-endorphin in normal human subjects. Neuroendocrinology 38:282-284
36. Mains RE, Eipper BA, Ling N (1977): Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74:3014-3018
37. Majeed NH, Lason W, Przewlocka B, Przewlocki R (1985a): Serotonergic regulation of the brain and gut beta-endorphin and dynorphin content in the rat. Pol J Pharmacol Pharm 37:909-918
38. Majeed NH, Lason W, Przewlocka B, Przewlocki R (1985b): Differential modulation of the beta-endorphin and dynorphin systems by serotonergic simulation in the rat. Neuropeptides 5:563-566
39. Meltzer HY, Maes M (1994): Effects of pindolol on 5-HTP-induced prolactin and cortisol responses. Psychopharmacol 114:635-643
40. Meltzer HY, Maes M (in press a): Effects of pindolol on mCPP-induced prolactin and cortisol responses in normal man. Psychiatr Res
41. Meltzer HY, Maes M (in press b): Effects of pindolol on MK-212-induced cortisol and prolactin responses in normal men. Biol Psychiatry
42. Meltzer HY, Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984): Effect of 5-hydroxytryptophan or serum cortisol levels in major affective disorders: Enhanced response in depression and mania. Arch Gen Psychiatry 41:366-374
43. Nakagami Y, Suda T, Yajima F (1986): Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from rat hypothalamus in vitro. Brain Res 386:232-236
44. Petraglia F, Facchinetti F, Martignoni E, Nappi G, Volpe A, Genazzani AR (1984): Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans. J Clin Endocrinol Metab 59:1138-1142
45. Rivier CL, Plotsky PM (1986): Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Ann Rev Physiol 48:475-494
46. Rupprecht R, Lesch KP, Muller U, Beck G, Beckmann H, Schulte HM (1989): Blunted adrenocorticotropin but normal β-endorphin release after human corticotropinreleasing hormone administration in depression. J Clin Endocrinol Metab 69:600-603
47. Sapun-Malcolm D, Farah JM Jr, Mueller GP (1986): Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo. Neuroendocrinology 42:191-196
48. Sapun-Malcolm D, Farah JM Jr, Mueller GP (1983): Evidence for serotonergic stimulation of pituitary beta-endorphin release: Preferential release from the anterior lobe in vivo. Life Sci 33:95-102.
49. Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallinson J, Lowry PJ, Besser GM, Rees LH (1981): Studies on circulating met-enkephalin and β-endorphin: Normal subjects and patients with renal and adrenal disease. Clin Endocrinol 15:291-295
50. Spitzer RL, Williams JBW, Gibbon M (1985): Structured Clinical Interview for DSM-III Patient Version. New York, New York State Psychiatric Institute, Biometrics Research Department
51. Thompson PA, Maes M, Meltzer HY (1994): Use of placebo controlled models in neuroendocrine challenge studies in psychiatry research. Psychiatr Res 52:317-326
52. Van de Kar LD, Carnes M, Maslowski RJ, et al. (1989): Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: Effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J Pharmacol Exp Ther 251:428-434
53. Wiedemann E, Saito T, Linfoot JA, Li CH (1979): Specific radioimmunoassay of human β-endorphin in unextracted plasma. J Clin Endocrinol Metab 49:478-480
54. Young EA, Lewis J, Akil H (1986): The preferential release of β-endorphin from the anterior pituitary lobe by corticotropin releasing factor (CRF). Peptides 7:603-607